AI Verdict
IMKTA has stronger fundamentals based on our AI analysis.
IMNM vs IMKTA Fundamental Comparison
| Metric | IMNM | IMKTA |
|---|---|---|
| Revenue | $6.9M | $1.4B |
| Net Income | $-212.4M | $28.1M |
| Net Margin | -3,060.0% | 2.0% |
| ROE | -33.5% | 1.7% |
| ROA | -31.1% | 1.1% |
| Current Ratio | 14.69x | 3.36x |
| Debt/Equity | 0.00x | 0.30x |
| EPS | $-2.43 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMNM vs IMKTA: Frequently Asked Questions
Is IMNM or IMKTA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMKTA has stronger fundamentals. IMNM is rated STRONG SELL (88% confidence) while IMKTA is rated SELL (72% confidence). This is not investment advice.
How does IMNM compare to IMKTA fundamentally?
Immunome Inc. has ROE of -33.5% vs INGLES MARKETS INC's 1.7%. Net margins are -3,060.0% vs 2.0% respectively.
Which stock pays higher dividends, IMNM or IMKTA?
IMNM has a dividend yield of N/A or no dividend while IMKTA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMNM or IMKTA for long term?
For long-term investing, consider that IMNM has STRONG SELL rating with 88% confidence, while IMKTA has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMNM vs IMKTA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMNM vs IMKTA, the AI consensus favors IMKTA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.